Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
None CAD 0.00(0%)
Last update at 2025-08-28T20:04:07.324539Z
Market Cap
54.36M

Momentum Score

…

Simply Better Brands Corp. operates as an omni-channel platform with diversified assets in the plant-based and wellness consumer product categories. The company focuses on plant-based, natural, and clean ingredient space. It focuses on consumer product categories, including CBD products, plant-based food and beverage, and pet care and skin care industries. The company offers Hemp derived products, including CBD under the Purekana, Seventh Sense, and Vibez brands; protein and nutritious bars under the Tru and TRUBAR brands through online in the U.S. and Canada, as well as through retailers; and skin care products under the No BS brand. The company was formerly known as PureK Holdings Corp. and changed its name to Simply Better Brands Corp. in May 2021. The company is headquartered in Vancouver, Canada. Simply Better Brands Corp. operates as a subsidiary of Heavenly Rx Ltd.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.18
Low
0.95
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
80.61M
Revenue Per Share
1.08
Gross Profit TTM
44.41M
Debt / Equity
-
ROE
-961.62%
Net Debt
17.11M
ROCE
136.73%
Diluted EPS TTM
-0.49

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -13.38M -12.87M -1.98M 5.77M -
Minority interest - - 0.72M 1.20M 1.20M
Net income -12.35M -12.82M -2.20M 2.89M -
Selling general administrative 49.44M 18.79M 10.51M 10.97M -
Gross profit 44.56M 9.71M 8.97M 16.82M -
Reconciled depreciation 4.73M 0.65M 0.05M 0.00M -
Ebit -9.69M - 1.36M 5.78M 3.87M
Ebitda -7.25M -9.87M -1.82M 5.78M -
Operating income -9.27M -8.68M -1.48M 5.78M -
Other operating expenses - - 0.00M 0.19M 0.11M
Interest expense 1.40M 2.34M 0.11M 0.00M 0.00M
Tax provision -1.03M -0.04M - - -
Interest income 0.00M 0.02M 0.02M 0.00M -
Net interest income -1.40M -2.32M -0.09M -0.00M -
Income tax expense -1.03M - - - -
Total revenue 65.41M 15.63M 13.77M 25.31M -
Total operating expenses 74.69M 24.31M 15.25M 19.53M -
Cost of revenue 20.85M 5.92M 4.80M 8.49M -
Total other income expense net -2.71M -1.87M -0.41M - -
Net income from continuing ops -12.35M -12.82M -1.98M 5.77M -
Net income applicable to common shares -12.35M -12.35M -1.98M 5.77M 3.94M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 19.54M 36.63M 21.81M 12.09M 3.72M
Intangible assets 1.53M 6.32M 9.53M - -
Other current assets 2.78M - 1.98M 1.87M 0.37M
Total liab 27.18M 25.49M 23.86M 25.80M 1.31M
Total stockholder equity -3.63M 12.59M -0.65M -14.43M 1.21M
Other current liab 0.36M 0.21M 0.11M 0.06M 0.12M
Common stock - 45.41M - 1.91M 2.41M
Capital stock 51.29M 45.41M 23.12M 1.91M 0.00M
Retained earnings -61.26M -39.57M -27.27M -16.49M 1.21M
Other liab - - - 5.47M -
Good will 3.90M 14.83M 5.24M - -
Other assets - 0.33M - 0.34M 0.01M
Cash 2.33M 2.34M 2.23M 8.31M 1.06M
Total current liabilities 26.63M 24.47M 18.51M 4.49M 1.22M
Net debt 17.11M 16.81M 18.39M 8.06M -
Short long term debt 18.89M 18.14M 16.31M 3.69M -
Other stockholder equity - 3.68M - 0.15M -
Property plant equipment - 0.01M - 0.08M 0.14M
Total current assets 14.10M 15.14M 6.67M 11.68M 3.57M
Net tangible assets - -8.56M - -14.43M 1.21M
Net receivables 2.37M 4.75M 0.40M 0.66M 0.86M
Long term debt 0.55M 1.02M 4.32M 12.68M -
Inventory 6.17M 3.55M 1.98M 0.83M 1.27M
Accounts payable 6.04M 6.12M 1.65M 0.37M 0.73M
Non currrent assets other - 0.33M 0.33M 0.33M -
Non current assets total 5.44M 21.49M 15.14M 0.41M 0.15M
Capital lease obligations - 0.00M 0.03M 0.08M 0.13M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 1.86M 1.86M 1.86M 1.86M -
Change to liabilities 2.97M 0.00M -0.43M 0.29M 0.70M
Total cashflows from investing activities 3.35M 3.35M -1.77M -0.01M -0.01M
Net borrowings -1.03M -1.03M 9.12M -0.00M -0.01M
Total cash from financing activities 1.49M 1.49M 8.07M -5.72M -1.83M
Change to operating activities -2.82M -2.82M -0.06M 0.00M -0.33M
Net income -12.35M -12.82M -1.98M 5.77M 3.94M
Change in cash 0.11M 0.11M 7.25M -0.26M 1.33M
Begin period cash flow 2.23M 8.31M 1.06M 1.33M -
End period cash flow 2.34M 2.23M 8.31M 1.06M 1.33M
Total cash from operating activities -4.76M -4.76M 0.95M 5.46M 3.17M
Issuance of capital stock 2.28M - - - -
Depreciation 4.73M 4.73M 0.05M 0.00M 0.00M
Dividends paid 0.00M 0.00M 0.35M 5.72M 1.82M
Change to inventory -1.01M -1.01M 0.44M -0.95M -0.47M
Change to account receivables -4.29M -4.29M 0.62M 0.30M -1.12M
Other cashflows from financing activities - -0.07M -0.70M -0.70M -0.70M
Change to netincome 7.96M 7.96M 2.31M 0.04M 0.45M
Capital expenditures 0.01M 0.01M 0.01M 0.01M 0.01M
Change in working capital -5.16M -1.54M 0.57M -0.36M -
Stock based compensation 4.73M 5.62M - - -
Other non cash items 2.12M 2.83M 1.94M - -
Free cash flow -5.09M -4.98M 0.95M 5.45M -

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
RX
Biosyent Inc.
0.30
1.78%
17.15 19.10 15.85 3.96 4.11 3.31 11.03
DB
Decibel Cannabis Company Inc
0.21
11.67%
2.01 - 8.67 0.67 1.20 0.99 17.75
ZYUS
ZYUS Life Sciences Corporation
0.03
9.38%
0.35 - - 108.48 4.41 140.29 -4.26
LSL
LSL Pharma Group Inc.
0.01
1.64%
0.31 20.75 - 1.88 1.89 2.85 10.19

Profile*

Simply Better Brands Corp

Simply Better Brands Corp. operates as an omni-channel platform with diversified assets in the plant-based and wellness consumer product categories. The company focuses on plant-based, natural, and clean ingredient space. It focuses on consumer product categories, including CBD products, plant-based food and beverage, and pet care and skin care industries. The company offers Hemp derived products, including CBD under the Purekana, Seventh Sense, and Vibez brands; protein and nutritious bars under the Tru and TRUBAR brands through online in the U.S. and Canada, as well as through retailers; and skin care products under the No BS brand. The company was formerly known as PureK Holdings Corp. and changed its name to Simply Better Brands Corp. in May 2021. The company is headquartered in Vancouver, Canada. Simply Better Brands Corp. operates as a subsidiary of Heavenly Rx Ltd.

206 ? 595 Howe Street, Vancouver, BC, Canada, V6C 2T5

855 553 7441

Name Title Year Born
Ms. Kathy Casey CEO & Director 1967
Mr. Jeff Yauck Co-Founder & Director 1989
Mr. Brian R. Meadows CFO, Corp. Sec. & Director 1963
Mr. J. R. Kingsley Ward B.A., B.Com. CEO & Chairman 1964
Mr. Brian R. Meadows CFO & Corporate Secretary 1964
Joe Wichser Vice President of Sales NA
Erica Groussman Chief Executive Officer of Tru Brands Inc. NA
Diana Briceno Chief Executive Officer of NO BS NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…